Wide Ranks

ACONW

0.0400

Top Statistics
Market Cap 0.0000 Forward PE 0.0000 Revenue Growth -35.70 %
Current Ratio 1.28 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins -10350.57 %
Balance Sheet
Total Cash 1 M Total Cash Per Share 0.1420 Total Debt 777087
Total Debt To Equity 47.32 Current Ratio 1.28 Book Value Per Share -0.8820
All Measures
Message Board Id finmb_108179695 Return On Equity -7.14 City Broomfield
Uuid 4606cc7d-c715-3e1e-ba16-155089590d5d Previous Close 0.0300 Book Value -0.8820
Beta 0.3960 Total Debt 777087 Volume 249
Fifty Two Week Low 0.0400 Total Cash Per Share 0.1420 Total Revenue 53947
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -10350.57 %
Net Income To Common -5900537 Trailing Peg Ratio None Total Cash 1 M
Revenue Per Share 0.0150 Trailing PE 0.0000 Regular Market Previous Close 0.0300
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Open 0.0399
Free Cashflow -3944406 State CO Dividend Yield 0.00 %
Return On Assets -1.15 Time Zone Short Name EST Trailing Eps -6.58
Day Low 0.0400 Address1 8181 Arista Place Target High Price 0.0000
Price Hint 4 Website https://www.aclarion.com Forward Eps 0.0000
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 85.90 %
Is_sp_500 False Regular Market Day High 0.0400 Profit Margins 0.00 %
Debt To Equity 47.32 Fifty Two Week High 0.0400 Day High 0.0400
Regular Market Open 0.0399 Industry Key health-information-services Earnings Growth 0.00 %
Revenue Growth -35.70 % Operating Cashflow -4979390 Currency USD
Time Zone Full Name America/New_York Is_nasdaq_100 False Market Cap 0.0000
Zip 80021 Quote Type EQUITY Industry Health Information Services
Long Name Aclarion, Inc. Regular Market Day Low 0.0400 Current Price 0.0400
Address2 Suite 100 Financial Currency USD Current Ratio 1.28
Gross Margins -51.53 % Industry Disp Health Information Services Country United States
Float Shares 7 M Forward PE 0.0000 Regular Market Volume 249
Ebitda -4525660 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States.

It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.

The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021.

Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.